Senetek PLC Announces Investor Conference Call on March 15
NAPA, Calif., March 12 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - news), senetekplc.com , a biopharmaceutical company that develops products in two key markets, anti-aging and sexual dysfunction, today announced that its management will conduct its fourth quarter and year-end teleconference call for investors on Friday, March 15, 2002. The call will be available both by telephone and at a Webcast by CCBN.
DATE: Friday, March 15, 2002
TIME: 1 p.m. Eastern Standard Time
DIAL-IN: Domestic: 800/665-0430
International: 913/981-5591
CONFIRMATION
CODE: 723212
REPLAY
NUMBERS: Domestic: 888/203-1112
International: 719/457-0820
WEBCAST: CCBN's individual investor center at
companyboardroom.com or at sites in CCBN's
Individual Investor Network such as America Online's
Personal Finance Channel.
INSTITUTIONAL
INVESTORS: Access the call using CCBN's password protected site
Street Events ( streetevents.com ).
CONTACT: Senetek Investor Relations, +1-707-226-3900, ext. 102
or Pknopick@eandecommunications.com.
Senetek PLC, headquartered in Napa, California, is a science driven biopharmaceutical company engaged in the development of skincare/dermatological and sexual dysfunction products. Kinetin, the Company's patented anti-aging skincare technology, has been licensed to leading cosmetics and dermatological companies worldwide. Invicorp(TM) is Senetek's technology for the treatment of erectile dysfunction, a condition suffered by more than 100 million men worldwide. To learn more about Senetek, visit the Company's Website at senetekplc.com .
SOURCE: Senetek PLC |
